Bharglob 16.5% Injection is a high-quality Human Normal Immunoglobulin (IVIG) formulation used in advanced immunotherapy and hospital-based critical care treatments. It is globally recognized for its role in managing immune deficiencies and autoimmune conditions.
Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter supplying Bharglob 16.5% Injection to international markets including hospitals, clinics, licensed pharmacies, distributors, and authorized personal import buyers across the United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Overview of Bharglob 16.5% IVIG Injection
Bharglob 16.5% Injection contains purified immunoglobulin G (IgG) derived from human plasma. It is designed to support immune system function in patients with antibody deficiencies and immune-mediated disorders.
This IVIG therapy is widely used in tertiary care hospitals and specialty treatment centers where immune modulation is required for both acute and long-term conditions.
Key Therapeutic Applications
Bharglob 16.5% Injection is commonly prescribed in clinical practice for:
- Primary and secondary immunodeficiency disorders
- Guillain-Barré Syndrome (GBS) management
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Immune Thrombocytopenic Purpura (ITP)
- Kawasaki disease treatment protocols
- Severe or recurrent bacterial and viral infections
- Autoimmune neurological and hematological conditions
Its immunomodulatory action helps restore immune balance and reduce disease severity in critical patients.
Global Pharmaceutical Export Strength of Cordium Pharmaceuticals
Cordium Pharmaceuticals Pvt Ltd is engaged in regulated pharmaceutical export operations with a focus on specialty injectables and hospital-grade medicines.
The company supports international healthcare procurement with:
- Verified pharmaceutical sourcing and supply chain integrity
- Temperature-controlled cold-chain logistics for IVIG products
- Export documentation and regulatory compliance assistance
- Hospital-grade packaging and secure international shipping
- Bulk supply capability for government and private healthcare sectors
- Flexible procurement options for distributors and importers
Export Destinations for Bharglob 16.5% Injection
Cordium Pharmaceuticals supplies Bharglob 16.5% Injection across major regulated and emerging healthcare markets:
- United States – Specialty clinics and hospital procurement networks
- Germany – Licensed pharmaceutical importers and healthcare systems
- United Kingdom – NHS-linked suppliers and private hospitals
- Netherlands – European distribution and pharmacy chains
- South Africa – Hospital supply and immunotherapy units
- United Arab Emirates – Private healthcare and specialty hospitals
- Brazil – National distributors and clinical procurement agencies
Product Handling & Administration Guidelines
Bharglob 16.5% Injection is administered via intravenous infusion under strict medical supervision. Dosage and infusion rate are determined by healthcare professionals based on patient condition, weight, and therapeutic response.
Proper cold storage (2°C to 8°C) is required to maintain product stability and efficacy throughout the supply chain.
Advantages of Choosing IVIG Supply from India
India has become a leading hub for global pharmaceutical exports, particularly in injectable and biologic therapies. Key advantages include:
- High manufacturing quality standards
- Competitive international pricing
- Strong regulatory compliance systems
- Reliable large-volume production capacity
- Efficient global distribution networks
Cordium Pharmaceuticals ensures consistent supply for urgent hospital requirements and long-term procurement contracts.
Order, Distribution & Business Enquiry
For hospital procurement, distributor partnerships, wholesale export, and personal import assistance, contact:
- WhatsApp: +91-9405117673
- Email: info@cordiumpharma.com
- Supplier: www.cordiumpharma.com
Global Healthcare Supply Commitment
Cordium Pharmaceuticals Pvt Ltd remains committed to delivering reliable, high-quality pharmaceutical export solutions that support hospitals, healthcare providers, and distributors worldwide with consistent access to essential IVIG therapy products like Bharglob 16.5% Injection.